Scholarly Index
Laura Puzniak
Pfizer (United States); 2,984 total citations; 152 total publications; best world rank #46
Pfizer (United States)
2,984Total citations
152Total publications
27H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Antibiotic Use and Resistance | Lifetime | 893 | US 307 | 95.10 |
| Nosocomial Infections in ICU | Lifetime | 676 | US 222 | 94.02 |
| COVID-19 Clinical Research Studies | 2021-2025 | 277 | US 77 | 98.65 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 533 | US 173 | 97.82 |
| Antibiotic Use and Resistance | 2021-2025 | 88 | US 20 | 97.61 |
| Nosocomial Infections in ICU | 2021-2025 | 46 | US 9 | 96.02 |
| Long-Term Effects of COVID-19 | 2021-2025 | 545 | US 125 | 95.25 |
| Pneumonia and Respiratory Infections | 2021-2025 | 352 | US 105 | 93.40 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 872 | US 159 | 81.78 |